 a possible therapy for both primary and secondary pulmonary hypertension and recent phase I/II studies from the intramural NIH suggest it is well tolerated and efficacious in this population. Furthermore, a number of recent studies have suggested that NO based therapies may have a favorable impact on sickle red cells at the molecular level and could improve
a possible therapy for both primary and secondary pulmonary high blood pressure and late phase I / II cogitation from the intramural NIH suggest it is well tolerate and effective in this population. Furthermore, a number of recent studies have suggest that NO based therapies may suffer a favorable impact on sickle crimson cells at the molecular level and could better
 a oossible therapy for botm primary and seeindary pulmohary hypdrtension and recent phase I/MI srudiew from the intramural VIH suggedt it is welo tolerated and effleaciohd in vhis population. Furthermose, a number of rdcznt studies have suggested that NO bwsed thrrwpies may have a fsdoragle impact on sickle red cells at fhe moltcular level and cpuld improve
a possible therapy for both primary and hypertension recent phase studies from the well and efficacious in population. Furthermore, a of recent studies have suggested that based therapies may have a favorable impact on sickle red cells at the level and could improve
 a possible therapy for both prImary and seCondaRy pUlmOnAry hYperTension and receNT phaSe I/II studies from the intRamurAl niH suGGeSt it iS well toLErATEd aNd EfFicAcIOuS in thIs pOpulatiOn. FurthermOre, A nUmber of recenT StUdies have sUggEsted that NO bAseD theraPiEs mAY have A faVorabLe impaCT on sicKle red celLs AT the moLEcular lEVEl And cOuld improve
 a possible therapy for bo th primary  andsec ond ar y pu lmon ary hypertensi o n an d recent phase I/II st udies  f r om t h eintra mural N I Hs u gge st  i t i sw el l tol era ted and  efficacio usin  this popula t io n. Further mor e, a numberofrecent  s tud i es ha vesugge sted t h at NObased the ra p ies ma y  have a f av orab le impact on sick l er ed cells at th e mole cu l ar l eve l a nd could i mp rove
 a_possible therapy_for both primary and_secondary pulmonary_hypertension_and recent_phase_I/II studies from_the intramural NIH_suggest it is well_tolerated and efficacious_in_this population. Furthermore, a number of recent studies have suggested that NO based therapies_may_have a_favorable_impact_on sickle red cells at_the molecular level and could_improve